ARTICLE | Company News
Cellectis, Celonic deal
April 9, 2007 7:00 AM UTC
ALCLS granted Celonic a worldwide, non-exclusive license to commercialize meganuclease-tagged mammalian cell lines that produce therapeutics developed using ALCLS' meganuclease recombination system (M...